Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-21-013248
Filing Date
2021-08-31
Accepted
2021-08-31 08:34:31
Documents
3
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp157141_6k.htm 6-K 10599
2 EXHIBIT 99.1 dp157141_ex9901.htm EX-99.1 18407
3 GRAPHIC image_001.jpg GRAPHIC 2324
  Complete submission text file 0000950103-21-013248.txt   33344
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 211225616
SIC: 2834 Pharmaceutical Preparations